Tranquil Clinical Research
- Company typePrivate
- Founded2013
- HeadquartersWebster, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Tranquil Clinical Research firmographics
Firmographics- Name
- Tranquil Clinical Research
- Legal name
- Tranquil Clinical Research
- Website
- https://tranquilclinicalresearch.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Tranquil Clinical Research industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Tranquil Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Webster
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Tranquil Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Full-Service CRO Services: Comprehensive clinical research organization services including study start-up, monitoring, data management, regulatory affairs, medical monitoring, and project management. Charged as professional services across the clinical trial lifecycle from Phase I through Phase IV.
- Phase I Unit Services: Hospital-based Phase I clinical research unit providing First-in-Human (FIH) trials, PK/PD studies, bioequivalence, and healthy volunteer trials with 36-bed capacity.
- Functional Service Provider (FSP): Tranquil Triumph FSP providing CRA oversight, training, and development services with bundled PM oversight, metrics, and QC visits included.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based professional services |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Tranquil Clinical Research product offering
Product offeringCore offering
Tranquil Clinical Research is a full-service Contract Research Organization (CRO) providing Phase I through Phase IV clinical trial services to pharmaceutical, biotechnology, and medical device sponsors. Offerings include study start-up, clinical trial monitoring, data management with EDC, medical monitoring and pharmacovigilance, regulatory affairs, project management, trial master file management, study rescue, and pre-clinical support, supplemented by a 36-bed hospital-based Phase I unit and a Functional Service Provider (Tranquil Triumph) model.
Product overview
Tranquil Clinical Research is a full-service Contract Research Organization (CRO) offering integrated clinical trial services from Phase I through full trial conduct. The portfolio includes a 36-bed free-standing Phase I Unit for First-in-Human studies, the Tranquil Triumph Functional Service Provider (FSP) model for sponsor oversight, and nine core service modules covering clinical trial monitoring, data management with EDC systems, medical monitoring and pharmacovigilance, pre-clinical phase support, project management, regulatory affairs, study rescue, study start-up, and trial master file management. The company also operates a specialized Surgical Clinical Trial Center. Services are designed to support sponsors from early drug development through trial completion, with emphasis on diverse participant enrollment and rapid enrollment capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Tranquil Triumph: Functional Service Provider (FSP) program offering CRA oversight, training, and development with certified GCP training, indication-specific training, and therapeutic expert training.
Products and services
- Clinical Trial Monitoring Monitoring of clinical trial conduct to ensure compliance with regulations, protocol, SOPs, and GCP through on-site visits and oversight activities for pharmaceutical, biotech, and device sponsors.
- Data Management & EDC Complete data management services including EDC system capabilities for user acceptance testing, SAE reconciliation, medical coding, data export, and functional reporting tools for clinical trial sponsors.
- Medical Monitoring & Pharmacovigilance Pharmacovigilance and medical monitoring services ensuring patient safety throughout clinical trials, including SAE processing and query generation for sponsors.
- Pre-Clinical Phase Services Pre-clinical research support including In-Vivo and In-Vitro experimentation, Fluorescence-Activated Cell Sorting (FACS), regulatory guidance, site identification, and protocol development for drug development sponsors.
- Project Management Full project management support with dedicated Clinical Project Managers handling study planning, execution, milestone setting, and sponsor expectation management for clinical trials.
- Regulatory Affairs Expertise in global regulatory laws and requirements for clinical trials, ensuring FDA compliance and rapid regulatory submissions from drug discovery through approval.
- Study Rescue Rescue services for clinical trials at any point in the lifecycle to overcome obstacles and challenges encountered during the trial for sponsors.
- Study Start-up Rapid study startup services using gap analysis to evaluate barriers, protocol analysis, and investigator/site identification for efficient clinical trial deployment.
- Trial Master File Ensures essential documents are properly completed and filed according to FDA and local regulations, with quality assurance steps including site training, QC reviews, and ALCOAC compliance.
- Phase I Unit 36-bed free-standing hospital-based clinical research unit in the Clear Lake NASA Medical Center complex conducting First-in-Human (FIH) trials, PK/PD studies, bioequivalence studies, and healthy volunteer trials with diverse participant enrollment.
- Surgical Clinical Trial Center Specialized clinical trial center dedicated to surgical device and intervention studies for medical device sponsors.
- Tranquil Triumph Functional Service Provider (FSP) Functional Service Provider model offering CRA oversight, training, and development with business continuity (CRA readiness within one week), cost effectiveness guarantees, and multiple monitoring types (centralized, decentralized, remote, on-site) for sponsors.
Quantifiable outcome
- Enrolled 200 subjects within 10 business days with 35% minority enrollment
- +5 more outcomes
Companies that use Tranquil Clinical Research
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Tranquil Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Tranquil Clinical Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- INmune Bio, Inc.coreTranquil served as CRO partner for INmune Bio's Phase II clinical trial of Quellor for COVID-19 pulmonary complications. Conducted all clinical trial operations including protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management, and clinical operations. First patient dosed at UofL Health – Jewish Hospital.
Scale indicators13 records
Recent moves6 records
Expansion highlights6 records
Tranquil Clinical Research competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Tranquil Clinical Research social profiles
Digital presenceTranquil Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tranquil Clinical Research leadership team
Management profileNumber of profiles
Profiles1 record
Tranquil Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tranquil Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tranquil Clinical Research
What does Tranquil Clinical Research do?
Tranquil Clinical Research is a full-service Contract Research Organization (CRO) providing Phase I through Phase IV clinical trial services to pharmaceutical, biotechnology, and medical device sponsors. Offerings include study start-up, clinical trial monitoring, data management with EDC, medical monitoring and pharmacovigilance, regulatory affairs, project management, trial master file management, study rescue, and pre-clinical support, supplemented by a 36-bed hospital-based Phase I unit and a Functional Service Provider (Tranquil Triumph) model.
Is Tranquil Clinical Research a public or private company?
Tranquil Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tranquil Clinical Research founded?
Tranquil Clinical Research was founded in 2013. It employs 51 to 100 people.
Where is Tranquil Clinical Research based?
Tranquil Clinical Research is headquartered in Webster, United States, in the North America region.
How does Tranquil Clinical Research make money?
Three revenue lines are on record. Full-Service CRO Services are the primary driver. The others are phase I Unit Services and functional Service Provider (FSP).
Does Tranquil Clinical Research have an API?
No public API is recorded for Tranquil Clinical Research.
What industry is Tranquil Clinical Research in?
Tranquil Clinical Research's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.